Japan has long been implementing policies to raise the volume share of generic drugs to help control rising healthcare costs. From 1 October, the country has newly started to charge extra for non-generic pharmaceutical products, excluding biopharma drugs, under several conditions.
When receiving a prescribed drug, if a patient insists on a non-generic option without any specific medical reasons from the prescribing physician, an extra charge will be levied, equal to the sum of a quarter of the
Key Takeaways
- Japan has started charging patients extra for non-generic drugs from 1 October to further raise generic use and control healthcare costs.
- The country aims raise the volume share of generics to 80% in all 47 prefectures, and to 65% on a price basis, by the end of March 2026
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?